|
|
|
|
Anika Therapeutics Inc (NASDAQ: ANIK) |
|
|
|
| |
Anika Therapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025
Quarterly Results, Trends, Rankings, Statistics
Anika Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 16.7, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2026. Anika Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, | |